
Reet Pharma Private Limited
About Reet Pharma Private Limited
Data last updated:
Reet Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the textile segment of the apparel and fashion sector. It was incorporated on 28 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC267072. Its GSTIN is 07AAGCR8709N1ZQ (Delhi).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors including Nikhil Khera and Vipul Khera.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 158 Vikas Puri, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.26 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹14.46 Lakh (net margin 2.3%) and EBITDA of ₹23.84 Lakh (EBITDA margin 3.8%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹43.04 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reet Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 158 Vikas Puri, New Delhi, Delhi, India – 110018
- IndustryAppreal & Fashion, Textile, Apparel, Leather
To see the full contact details of Reet Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Reet Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Reet Pharma Private Limited, buy the company report.
Financials of Reet Pharma Private Limited
FY 2025 filings availableReet Pharma Private Limited reported revenue of ₹6.26 Cr (up 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reet Pharma Private Limited, buy the company report.
Board of directors of Reet Pharma Private Limited
Reet Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Khera | Director | 28 Mar 2014 | 12 Years 7 Months | Current |
| Vipul Khera | Director | 03 Jul 2015 | 11 Years 4 Months | Current |
| Raj Kumar Also directs: Raju Medicos Private Limited | Director | 28 Mar 2014 | 12 Years 7 Months | Current |
Peer comparison
Reet Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Consumer Services industry (Pharma Retail and Distribution, Professional Services), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phoenix Cardio Care India Private Limited | ₹6.26 Cr (FY 2016) | -52.0% | Kolkata, West Bengal, India | |||
| Reet Pharma Private Limitedthis company | ₹6.26 Cr (FY 2024) | ₹14.46 Lakh | 2.3% | 15.0% | New Delhi, Delhi, India | |
| Hi-Tec Laboratories Pvt. Ltd. | ₹6.25 Cr (FY 2025) | 1.0% | Patna, Bihar, India | |||
| Bhandaree Consumer Products Private Limited | ₹6.25 Cr (FY 2025) | 139.0% | Mumbai, Maharashtra, India | |||
| Sach Pharmatech Private Limited | ₹6.24 Cr (FY 2025) | 41.0% | Delhi, India |
To see the full peer comparison of Reet Pharma Private Limited, buy the company report.
Auditor
Reet Pharma Private Limited is audited by PRAHLAD for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAHLAD | FY 2017 | 080944 |
Shareholding
The shareholding of Reet Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Reet Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2024 | 101013875 | Hdfc Bank Limited | ₹10.13 Lakh | Open | |
| 28 Oct 2024 | 101013873 | Hdfc Bank Limited | ₹15.16 Lakh | Open | |
| 30 Oct 2020 | 100412128 | Hdfc Bank Limited | ₹17.75 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Reet Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reet Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Reet Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCR8709N1ZQ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Reet Pharma Private Limited, buy the company report.
Recent activity
Reet Pharma Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Vipul Khera was appointed as Director on 03 Jul 2015.
Frequently asked questions
Reet Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in textile, within the apparel and fashion industry. It was incorporated on 28 March 2014 (12+ years old) and is registered under CIN U24100DL2014PTC267072.
Reet Pharma has 3 current directors:
- Nikhil Khera - Director
- Vipul Khera - Director
- Raj Kumar - Director
The latest financial statements of Reet Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Reet Pharma is 07AAGCR8709N1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Reet Pharma is U24100DL2014PTC267072. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reet Pharma was incorporated on 28 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Reet Pharma by revenue are Phoenix Cardio Care India Private Limited, Hi-Tec Laboratories Pvt. Ltd, Bhandaree Consumer Products Private Limited, Sach Pharmatech Private Limited, all in the Consumer Services industry (Pharma Retail and Distribution, Professional Services), with the same principal business activity (wholesale trading).
Vipul Khera was appointed as Director on 03 Jul 2015. Nikhil Khera was appointed as Director on 28 Mar 2014. Raj Kumar was appointed as Director on 28 Mar 2014.
The registered office of Reet Pharma is at C – 158 Vikas Puri, New Delhi, Delhi, India – 110018.
Reet Pharma operates in the apparel and fashion industry, in the textile segment.
Reet Pharma has open charges of ₹43.04 Lakh and no satisfied charges on record as per latest MCA filings.

